Pacific Biosciences of California Inc (PACB)
1.55
+0.09
(+6.16%)
USD |
NASDAQ |
Apr 19, 16:00
1.55
0.00 (0.00%)
After-Hours: 18:22
Pacific Biosciences of California Cash from Financing (TTM): 108.89M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 108.89M |
| September 30, 2023 | 191.31M |
| June 30, 2023 | 195.23M |
| March 31, 2023 | 200.40M |
| December 31, 2022 | 9.622M |
| September 30, 2022 | 10.13M |
| June 30, 2022 | 306.65M |
| March 31, 2022 | 309.08M |
| December 31, 2021 | 1.170B |
| September 30, 2021 | 1.294B |
| June 30, 2021 | 1.102B |
| March 31, 2021 | 1.099B |
| December 31, 2020 | 251.84M |
| September 30, 2020 | 144.09M |
| June 30, 2020 | 37.28M |
| March 31, 2020 | 38.06M |
| December 31, 2019 | 26.55M |
| September 30, 2019 | 13.70M |
| June 30, 2019 | 79.89M |
| March 31, 2019 | 78.40M |
| December 31, 2018 | 107.18M |
| September 30, 2018 | 102.00M |
| June 30, 2018 | 37.88M |
| March 31, 2018 | 100.87M |
| December 31, 2017 | 68.81M |
| Date | Value |
|---|---|
| September 30, 2017 | 68.91M |
| June 30, 2017 | 69.53M |
| March 31, 2017 | 39.38M |
| December 31, 2016 | 65.93M |
| September 30, 2016 | 95.29M |
| June 30, 2016 | 94.75M |
| March 31, 2016 | 63.99M |
| December 31, 2015 | 36.46M |
| September 30, 2015 | 24.80M |
| June 30, 2015 | 23.07M |
| March 31, 2015 | 21.47M |
| December 31, 2014 | 41.99M |
| September 30, 2014 | 24.41M |
| June 30, 2014 | 25.11M |
| March 31, 2014 | 36.07M |
| December 31, 2013 | 42.77M |
| September 30, 2013 | 42.45M |
| June 30, 2013 | 41.69M |
| March 31, 2013 | 30.61M |
| December 31, 2012 | 2.705M |
| September 30, 2012 | 2.96M |
| June 30, 2012 | 6.112M |
| March 31, 2012 | 9.165M |
| December 31, 2011 | 7.743M |
| September 30, 2011 | 218.98M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
9.622M
Minimum
Dec 2022
1.294B
Maximum
Sep 2021
346.71M
Average
191.31M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
| Integer Holdings Corp | -18.01M |
| Cerus Corp | 10.67M |
| Axogen Inc | 1.954M |
| AVITA Medical Inc | 40.37M |
| Intellia Therapeutics Inc | 130.32M |